Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 DNA Sequencing
1.2.3 RNA Sequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.2.6 Other
1.3 Market by Application
1.3.1 Global NGS Based Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS Based Diagnostics Market Perspective (2018-2033)
2.2 NGS Based Diagnostics Growth Trends by Region
2.2.1 Global NGS Based Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 NGS Based Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 NGS Based Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 NGS Based Diagnostics Market Dynamics
2.3.1 NGS Based Diagnostics Industry Trends
2.3.2 NGS Based Diagnostics Market Drivers
2.3.3 NGS Based Diagnostics Market Challenges
2.3.4 NGS Based Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS Based Diagnostics Players by Revenue
3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2018-2023)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS Based Diagnostics Revenue
3.4 Global NGS Based Diagnostics Market Concentration Ratio
3.4.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2022
3.5 NGS Based Diagnostics Key Players Head office and Area Served
3.6 Key Players NGS Based Diagnostics Product Solution and Service
3.7 Date of Enter into NGS Based Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS Based Diagnostics Breakdown Data by Type
4.1 Global NGS Based Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2024-2033)
5 NGS Based Diagnostics Breakdown Data by Application
5.1 Global NGS Based Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America NGS Based Diagnostics Market Size (2018-2033)
6.2 North America NGS Based Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America NGS Based Diagnostics Market Size by Country (2018-2023)
6.4 North America NGS Based Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS Based Diagnostics Market Size (2018-2033)
7.2 Europe NGS Based Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe NGS Based Diagnostics Market Size by Country (2018-2023)
7.4 Europe NGS Based Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS Based Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific NGS Based Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific NGS Based Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific NGS Based Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS Based Diagnostics Market Size (2018-2033)
9.2 Latin America NGS Based Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America NGS Based Diagnostics Market Size by Country (2018-2023)
9.4 Latin America NGS Based Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS Based Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa NGS Based Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa NGS Based Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa NGS Based Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Detail
11.1.2 Janssen Business Overview
11.1.3 Janssen NGS Based Diagnostics Introduction
11.1.4 Janssen Revenue in NGS Based Diagnostics Business (2018-2023)
11.1.5 Janssen Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche NGS Based Diagnostics Introduction
11.2.4 Roche Revenue in NGS Based Diagnostics Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen NGS Based Diagnostics Introduction
11.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2018-2023)
11.3.5 Qiagen Recent Development
11.4 ThermoFisher Scientific
11.4.1 ThermoFisher Scientific Company Detail
11.4.2 ThermoFisher Scientific Business Overview
11.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
11.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2018-2023)
11.4.5 ThermoFisher Scientific Recent Development
11.5 Oxford Gene Technology
11.5.1 Oxford Gene Technology Company Detail
11.5.2 Oxford Gene Technology Business Overview
11.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
11.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2018-2023)
11.5.5 Oxford Gene Technology Recent Development
11.6 Illumina
11.6.1 Illumina Company Detail
11.6.2 Illumina Business Overview
11.6.3 Illumina NGS Based Diagnostics Introduction
11.6.4 Illumina Revenue in NGS Based Diagnostics Business (2018-2023)
11.6.5 Illumina Recent Development
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Detail
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
11.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2018-2023)
11.7.5 Pacific Biosciences Recent Development
11.8 Paradigm Diagnostics
11.8.1 Paradigm Diagnostics Company Detail
11.8.2 Paradigm Diagnostics Business Overview
11.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
11.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2018-2023)
11.8.5 Paradigm Diagnostics Recent Development
11.9 Innogene Kalbiotech
11.9.1 Innogene Kalbiotech Company Detail
11.9.2 Innogene Kalbiotech Business Overview
11.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
11.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2018-2023)
11.9.5 Innogene Kalbiotech Recent Development
11.10 Admera Health
11.10.1 Admera Health Company Detail
11.10.2 Admera Health Business Overview
11.10.3 Admera Health NGS Based Diagnostics Introduction
11.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2018-2023)
11.10.5 Admera Health Recent Development
11.11 AITbiotech
11.11.1 AITbiotech Company Detail
11.11.2 AITbiotech Business Overview
11.11.3 AITbiotech NGS Based Diagnostics Introduction
11.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2018-2023)
11.11.5 AITbiotech Recent Development
11.12 Centogene
11.12.1 Centogene Company Detail
11.12.2 Centogene Business Overview
11.12.3 Centogene NGS Based Diagnostics Introduction
11.12.4 Centogene Revenue in NGS Based Diagnostics Business (2018-2023)
11.12.5 Centogene Recent Development
11.13 Phalanx Biotech Group
11.13.1 Phalanx Biotech Group Company Detail
11.13.2 Phalanx Biotech Group Business Overview
11.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
11.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2018-2023)
11.13.5 Phalanx Biotech Group Recent Development
11.14 iGenomX
11.14.1 iGenomX Company Detail
11.14.2 iGenomX Business Overview
11.14.3 iGenomX NGS Based Diagnostics Introduction
11.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2018-2023)
11.14.5 iGenomX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of DNA Sequencing
Table 3. Key Players of RNA Sequencing
Table 4. Key Players of Whole Genome Sequencing
Table 5. Key Players of Whole Exome Sequencing
Table 6. Key Players of Other
Table 7. Global NGS Based Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global NGS Based Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global NGS Based Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global NGS Based Diagnostics Market Share by Region (2018-2023)
Table 11. Global NGS Based Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global NGS Based Diagnostics Market Share by Region (2024-2033)
Table 13. NGS Based Diagnostics Market Trends
Table 14. NGS Based Diagnostics Market Drivers
Table 15. NGS Based Diagnostics Market Challenges
Table 16. NGS Based Diagnostics Market Restraints
Table 17. Global NGS Based Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global NGS Based Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2022)
Table 20. Ranking of Global Top NGS Based Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by NGS Based Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players NGS Based Diagnostics Product Solution and Service
Table 24. Date of Enter into NGS Based Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global NGS Based Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global NGS Based Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global NGS Based Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global NGS Based Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global NGS Based Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global NGS Based Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global NGS Based Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global NGS Based Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America NGS Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America NGS Based Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America NGS Based Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe NGS Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe NGS Based Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe NGS Based Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific NGS Based Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific NGS Based Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific NGS Based Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America NGS Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America NGS Based Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America NGS Based Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa NGS Based Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa NGS Based Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa NGS Based Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Janssen Company Detail
Table 50. Janssen Business Overview
Table 51. Janssen NGS Based Diagnostics Product
Table 52. Janssen Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Janssen Recent Development
Table 54. Roche Company Detail
Table 55. Roche Business Overview
Table 56. Roche NGS Based Diagnostics Product
Table 57. Roche Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Roche Recent Development
Table 59. Qiagen Company Detail
Table 60. Qiagen Business Overview
Table 61. Qiagen NGS Based Diagnostics Product
Table 62. Qiagen Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 63. Qiagen Recent Development
Table 64. ThermoFisher Scientific Company Detail
Table 65. ThermoFisher Scientific Business Overview
Table 66. ThermoFisher Scientific NGS Based Diagnostics Product
Table 67. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 68. ThermoFisher Scientific Recent Development
Table 69. Oxford Gene Technology Company Detail
Table 70. Oxford Gene Technology Business Overview
Table 71. Oxford Gene Technology NGS Based Diagnostics Product
Table 72. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Oxford Gene Technology Recent Development
Table 74. Illumina Company Detail
Table 75. Illumina Business Overview
Table 76. Illumina NGS Based Diagnostics Product
Table 77. Illumina Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Illumina Recent Development
Table 79. Pacific Biosciences Company Detail
Table 80. Pacific Biosciences Business Overview
Table 81. Pacific Biosciences NGS Based Diagnostics Product
Table 82. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 83. Pacific Biosciences Recent Development
Table 84. Paradigm Diagnostics Company Detail
Table 85. Paradigm Diagnostics Business Overview
Table 86. Paradigm Diagnostics NGS Based Diagnostics Product
Table 87. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 88. Paradigm Diagnostics Recent Development
Table 89. Innogene Kalbiotech Company Detail
Table 90. Innogene Kalbiotech Business Overview
Table 91. Innogene Kalbiotech NGS Based Diagnostics Product
Table 92. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Innogene Kalbiotech Recent Development
Table 94. Admera Health Company Detail
Table 95. Admera Health Business Overview
Table 96. Admera Health NGS Based Diagnostics Product
Table 97. Admera Health Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Admera Health Recent Development
Table 99. AITbiotech Company Detail
Table 100. AITbiotech Business Overview
Table 101. AITbiotech NGS Based Diagnostics Product
Table 102. AITbiotech Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 103. AITbiotech Recent Development
Table 104. Centogene Company Detail
Table 105. Centogene Business Overview
Table 106. Centogene NGS Based Diagnostics Product
Table 107. Centogene Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Centogene Recent Development
Table 109. Phalanx Biotech Group Company Detail
Table 110. Phalanx Biotech Group Business Overview
Table 111. Phalanx Biotech Group NGS Based Diagnostics Product
Table 112. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Phalanx Biotech Group Recent Development
Table 114. iGenomX Company Detail
Table 115. iGenomX Business Overview
Table 116. iGenomX NGS Based Diagnostics Product
Table 117. iGenomX Revenue in NGS Based Diagnostics Business (2018-2023) & (US$ Million)
Table 118. iGenomX Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS Based Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global NGS Based Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. DNA Sequencing Features
Figure 4. RNA Sequencing Features
Figure 5. Whole Genome Sequencing Features
Figure 6. Whole Exome Sequencing Features
Figure 7. Other Features
Figure 8. Global NGS Based Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global NGS Based Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Academics/Research Institutions Case Studies
Figure 13. NGS Based Diagnostics Report Years Considered
Figure 14. Global NGS Based Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global NGS Based Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global NGS Based Diagnostics Market Share by Region: 2022 VS 2033
Figure 17. Global NGS Based Diagnostics Market Share by Players in 2022
Figure 18. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2022
Figure 20. North America NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America NGS Based Diagnostics Market Share by Country (2018-2033)
Figure 22. United States NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe NGS Based Diagnostics Market Share by Country (2018-2033)
Figure 26. Germany NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific NGS Based Diagnostics Market Share by Region (2018-2033)
Figure 34. China NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America NGS Based Diagnostics Market Share by Country (2018-2033)
Figure 42. Mexico NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa NGS Based Diagnostics Market Share by Country (2018-2033)
Figure 46. Turkey NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia NGS Based Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 50. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 51. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 52. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 53. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 54. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 55. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 56. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 57. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 58. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 59. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 60. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 61. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed